首页> 外文期刊>American journal of medical genetics, Part A >GALNS mutations in Indian patients with mucopolysaccharidosis IVA
【24h】

GALNS mutations in Indian patients with mucopolysaccharidosis IVA

机译:印度黏多糖贮积症IVA患者的GALNS突变

获取原文
获取原文并翻译 | 示例
           

摘要

Mucopolysaccharidosis IV A (Morquio syndrome A, MPS IVA) is a lysosomal storage disease caused by the deficiency of N-acetylgalactosamine-6-sulfatase (GALNS). The mutation spectrum in this condition is yet to be determined in Indians. We aimed to analyze the mutations in the GALNS gene in Asian Indians with MPS IVA. All the exons and the adjacent intronic regions of the gene were amplified and sequenced in sixty-eight unrelated Indian families. We identified 136 mutant alleles comprising of 40 different mutations. We report twenty-two novel mutations that comprise of seventeen missense (p.Asn32Thr, p.Leu36Arg, p.Pro52Leu, p.Pro77Ser, p.Cys79Arg, p.His142Pro, p.Tyr191Asp, p.Asn204Thr, p.Gly188Ser, p.Phe216Ser, p.Trp230Cys, p.Ala291Ser, p.Gly317Arg, p.His329Pro, p.Arg386Ser, p.Glu450Gly, p.Cys501Ser), three splice-site variants (c.120+1G>C, c.1003-3C>G, c.1139+1G>A), one nonsense mutation (p.Gln414*) and one frameshift mutation (p.Pro420Leufs*440). Eighteen mutations have been reported earlier. Among these p.Ser287Leu (8.82%), p.Phe216Ser (7.35%), p.Asn32Thr (6.61%) and p.Ala291Ser (5.88%) were the most frequent mutations in Indian patients but were rare in the mutational profiles reported in other populations. These results indicate that the Indian patients may have a distinct mutation spectrum compared to those of other populations. Mutant alleles in exon 1, 7 and 8 accounted for 44.8% of the mutations, and sequencing of these exons initially may be a cost-effective approach in Asian Indian patients. This is the largest study on molecular analysis of patients with MPS IVA reported in the literature, and the first report from India.
机译:粘多糖贮积症IV A(Morquio综合征A,MPS IVA)是一种溶酶体贮积病,由N-乙酰半乳糖胺-6-硫酸酯酶(GALNS)缺乏引起。这种情况下的突变谱尚未在印第安人中确定。我们旨在分析具有MPS IVA的亚洲印度人GALNS基因中的突变。该基因的所有外显子和相邻的内含子区域均在68个无关的印度家族中进行了扩增和测序。我们鉴定了由40个不同突变组成的136个突变等位基因。我们报告了22个新颖的突变,包括十七个错义(p.Asn32Thr,p.Leu36Arg,p.Pro52Leu,p.Pro77Ser,p.Cys79Arg,p.His142Pro,p.Tyr191Asp,p.Asn204Thr,p.Gly188Ser,p .Phe216Ser,p.Trp230Cys,p.Ala291Ser,p.Gly317Arg,p.His329Pro,p.Arg386Ser,p.Glu450Gly,p.Cys501Ser),三个剪接位点变体(c.120 + 1G> C,c.1003- 3C> G,c.1139 + 1G> A),一个无意义突变(p.Gln414 *)和一个移码突变(p.Pro420Leufs * 440)。较早报道了十八种突变。这些p.Ser287Leu(8.82%),p.Phe216Ser(7.35%),p.Asn32Thr(6.61%)和p.Ala291Ser(5.88%)是印度患者中最常见的突变,但在其他人群。这些结果表明,与其他人群相比,印度患者可能具有独特的突变谱。外显子1、7和8中的突变等位基因占突变的44.8%,这些外显子的测序最初可能是亚洲印度裔患者的一种经济有效的方法。这是文献中报道的最大的MPS IVA患者分子分析研究,也是印度的第一篇报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号